Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Oncol.

Sec. Surgical Oncology

Volume 15 - 2025 | doi: 10.3389/fonc.2025.1655088

This article is part of the Research TopicExploring Robotic-Assisted Techniques in Urologic Oncology: Challenges and Future DirectionsView all 6 articles

First evidence of Retzius-sparing robot-assisted radical prostatectomy with the Versius robotic surgical system

Provisionally accepted
Erika  PalagoniaErika PalagoniaStefano  TapperoStefano TapperoElio  MazzoneElio Mazzone*Francesco  ChierigoFrancesco ChierigoCarlo  BurattoCarlo BurattoAlberto  CavigliaAlberto CavigliaMichele  BarbieriMichele BarbieriOfir  MaltzmanOfir MaltzmanValerio  CelliniValerio CelliniGiancarlo  NapoliGiancarlo NapoliAlberto  OliveroAlberto OliveroElena  StradaElena StradaDario  Di TrapaniDario Di TrapaniGiovanni  PetraliaGiovanni PetraliaSilvia  SeccoSilvia SeccoAldo  Massimo BocciardiAldo Massimo BocciardiAntonio  GalfanoAntonio GalfanoPaolo  Dell'oglioPaolo Dell'oglio
  • Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Milan, Italy

The final, formatted version of the article will be published soon.

We describe the first experience of Retzius-sparing robot-assisted radical prostatectomy (RS-RARP) performed with the Versius robotic system (CMR Surgical, Cambridge, UK). Five patients underwent RS-RARP at ASST Grande Ospedale Metropolitano Niguarda (Milan, Italy) between May 2023 and December 2023. All procedures were completed with no complications or need for conversion.No arms collision or technical failure of the system was recorded. The median operative time was 244 minutes (interquartile range [IQR]: 190-300). Median length of stay was three days. Our initial experience suggests that RS-RARP with the Versius robotic system is a feasible procedure. This novel platform provides a flexible system environment that can be easily tailored to all types of surgery.However, some arrangements are still necessary, warranting future investigations in larger series.

Keywords: Retzius-sparing, Prostatectomy, Versius, robotic surgery, prostate cancer

Received: 27 Jun 2025; Accepted: 18 Aug 2025.

Copyright: © 2025 Palagonia, Tappero, Mazzone, Chierigo, Buratto, Caviglia, Barbieri, Maltzman, Cellini, Napoli, Olivero, Strada, Trapani, Petralia, Secco, Bocciardi, Galfano and Dell'oglio. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Elio Mazzone, Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Milan, Italy

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.